SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Spinal Cord Stimulation Market Recap.
The US Spinal Cord Stimulation (SCS) market saw another quarter of exceptional growth in Q118, yet the market decelerated QoQ, posting 23% growth vs 24.6% growth in Q417. While seasonal trends were behind the QoQ slowdown ...
Among the many topics covered in the full Q118 SCS Market Recap are:
- Market Overview
- Across the Board Double-Digit Growth
- Abbott Still No. 1
- Boston Scientific Posts Solid Growth
- Medtronic Gaining Ground
- Nevro: Mixed Results in Q118
- Selected Regulatory and Clinical Highlights in Q118
Read entire Market Recap including news, data and analysis*...
*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.